Category: News

AI Compliance and Supply Chain Challenges in Life Sciences

As life sciences companies expand internationally, regulatory readiness becomes a strategic capability essential for global business planning. The upcoming Fireside Chat at the J.P. Morgan Healthcare Conference will explore how companies can navigate complex regulatory frameworks and the impacts of the new BIOSECURE Act on supply chains.

Read More »

FDA Clarifies Regulation for AI Health Devices

The FDA announced that consumer wearables providing general health information, such as calorie counters or sleep monitors, will not be subject to regulation. This decision supports AI development in healthcare while ensuring patients do not rely on unverified data for medical decisions.

Read More »

J.P. Morgan’s Bold Move: Ditching Proxy Advisors for AI Voting

J.P. Morgan Asset & Wealth Management announced it will stop using third-party proxy advisory firms for U.S. proxy voting, opting for its AI-powered internal platform, Proxy IQ. This move reflects increased regulatory scrutiny and signals a shift toward more customized voting recommendations in the proxy advisory industry.

Read More »

AI Regulation Takes Center Stage in South Carolina

Amid national efforts toward deregulation, South Carolina is considering AI regulations in response to an MIT report highlighting AI’s potential to replace 11.7% of U.S. jobs. Local advocates emphasize the importance of state-level protections to ensure user safety and data privacy.

Read More »